Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenue, net of returns, allowances and discounts $ 5,381 $ 4,125
Cost of revenues 1,704 1,515
Gross profit 3,677 2,610
Operating expenses    
Selling, general and administrative 7,029 7,588
Royalties 266 186
Research and product development 0 111
Transactional costs 923 634
Change in fair value of contingent consideration liability 0 35
Total operating expenses 8,218 8,554
Loss from operations (4,541) (5,944)
Other (expense) income    
Interest expense (548) (573)
Interest income 1 2
Change in fair value of warrant liability (19) 118
Warrant modification expense 0 (770)
Total other expense (566) (1,223)
Loss from continuing operations before tax (5,107) (7,167)
Income tax expense (3) (3)
Loss from continuing operations (5,110) (7,170)
Discontinued operations:    
Income from discontinued operations, net of tax of $0 for the three months ended March 31, 2018 and 2017 0 172
Net loss $ (5,110) $ (6,998)
Net loss per basic and diluted common share:    
Loss from continuing operations $ (1.19) $ (2.33)
Income from discontinued operations 0 0.06
Net loss per basic and diluted common share $ (1.19) $ (2.27)
Weighted average shares used in computing net loss per basic and diluted common share 4,302,608 3,071,342